home / stock / grtx / grtx news

GRTX News and Press, Galera Therapeutics Inc. From 08/14/23

Stock Information
Company Name: Galera Therapeutics Inc.
Stock Symbol: GRTX
Market: NYSE
Website: galeratx.com
Menu
GRTX GRTX Quote GRTX Short GRTX News GRTX Articles GRTX Message Board
Get GRTX Alerts

News, Short Squeeze, Breakout and More Instantly...
GRTX - Galera Reports Second Quarter 2023 Financial Results and Recent Corporate Updates

Company received Complete Response Letter from FDA for avasopasem and intends to request Type A meeting with FDA to discuss potential next steps Cash runway extended into Q2 2024 in connection with reduction in workforce FDA granted orphan drug designation to rucosopasem for the...
GRTX - Galera cut to Underperform at BofA after FDA snub for lead asset

2023-08-11 09:17:54 ET Galera Therapeutics ( NASDAQ: GRTX ) traded ~12% lower in the pre-market Friday after Bank of America downgraded the nano-cap biotech due to the FDA’s recent rejection of its lead candidate, avasopasem manganese, for a radiotherapy-induced complicat...

GRTX - LGHL and EBIX among mid-day movers

2023-08-10 13:25:55 ET Gainers: WeWork ( WE ) +87% . Capri Holdings Limited ( CPRI ) +56% . Black Spade Acquisition ( BSAQ ) +58% . Edible Garden AG Incorporated ( EDBL ) +43% . Lion Group Holding Ltd. ( LGHL ) +37% . Precige...

GRTX - LifeMD, Precigen top healthcare gainers; Galera, Virios lead losers' pack

2023-08-10 10:27:32 ET Gainers: LifeMD ( LFMD ) +20% . Precigen ( PGEN ) +19% . Repare Therapeutics ( RPTX ) +16% . Cosmos Health ( COSM ) +13% . GoodRx Holdings ( GDRX ) +13% . Losers: Galera Therapeutics ( GRTX ) -...
GRTX - ONDS, UP and HOTH among pre-market losers

2023-08-10 08:25:22 ET Galera Therapeutics ( GRTX ) -82% . Origin Materials ( ORGN ) -57% after Q2 earning release . Organogenesis Holdings ( ORGO ) -32% after Q2 earning release . Renovaro Biosciences ( RENB ) -23% . Wolverine World...

GRTX - FDA rejects Galera's treatment for mouth sores in cancer patients, stock -83% after hours

2023-08-09 17:17:06 ET Galera Therapeutics ( NASDAQ: GRTX ) on Wednesday said its new drug application for its treatment for a radiotherapy-induced complication had been rejected by the U.S. Food and Drug Administration (FDA). Shares of the micro-cap clinical-stage biopharma c...

GRTX - Galera Receives Complete Response Letter from U.S. FDA for Avasopasem Manganese

The Company remains committed to its goal of bringing avasopasem to patients and intends to meet with FDA as soon as possible to discuss potential next steps Galera will take actions to extend its cash runway and continue enrolling its rucosopasem clinical trials Conference call...
GRTX - ATRA, NGM and AMAT among after hour movers

2023-08-04 17:35:56 ET Gainers: Atara Biotherapeutics ( ATRA ) +5% . NGM Biopharmaceuticals ( NGM ) +5% . Galera Therapeutics ( GRTX ) +4% . Ovid Therapeutics ( OVID ) +3% . Magnite ( MGNI ) +3% . Losers: Applied Material...

GRTX - Galera: Even Chance Of Success Or Failure In The Upcoming PDUFA

2023-07-31 09:55:03 ET Summary GRTX has a PDUFA in 10 days. The stock is trading sideways. That is because the phase 3 trial was a success, but barely. I covered Galera Therapeutics ( GRTX ) in December 2021, and since then, the stock has lost a lot of value....

GRTX - RenovoRx, Immunome top healthcare gainers; BioXcel, CorMedix among losers

2023-06-29 10:10:59 ET Gainers: RenovoRx ( RNXT ) +37% . Immunome ( IMNM ) +36% .  DermTech ( DMTK ) +15% . Galera Therapeutics ( GRTX ) +9% . Oncolytics Biotech ( ONCY ) +7% . Losers: BioXcel Therapeutics ( BTA...
Previous 10 Next 10